Reported Consolidated quarterly numbers for SOLARA ACTIVE PHARMA SCIENCES are:
Net Sales at Rs 273.01 crore in March 2025 down 8.82% from Rs. 299.43 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 2.10 crore in March 2025 up 99.18% from Rs. 255.34 crore in March 2024.
EBITDA stands at Rs. 51.32 crore in March 2025 up 347.82% from Rs. 11.46 crore in March 2024.
SOLARA ACTIVE P shares closed at 575.60 on May 13, 2025 (NSE)
Story continues below Advertisement
| SOLARA ACTIVE PHARMA SCIENCES | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 273.01 | 300.31 | 299.43 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 273.01 | 300.31 | 299.43 | | EXPENDITURE | | Consumption of Raw Materials | 143.67 | 143.96 | 158.38 | | Purchase of Traded Goods | 5.05 | -- | 0.15 | | Increase/Decrease in Stocks | -30.63 | -9.10 | 1.45 | | Power & Fuel | -- | -- | -- | | Employees Cost | 52.29 | 51.67 | 56.01 | | Depreciation | 24.30 | 24.54 | 25.25 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 57.26 | 56.10 | 73.68 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 21.07 | 33.14 | -15.49 | | Other Income | 5.95 | 1.49 | 1.70 | | P/L Before Int., Excpt. Items & Tax | 27.02 | 34.63 | -13.79 | | Interest | 29.12 | 26.54 | 30.69 | | P/L Before Exceptional Items & Tax | -2.10 | 8.09 | -44.48 | | Exceptional Items | -- | -- | -122.18 | | P/L Before Tax | -2.10 | 8.09 | -166.66 | | Tax | -- | -- | 88.79 | | P/L After Tax from Ordinary Activities | -2.10 | 8.09 | -255.45 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.10 | 8.09 | -255.45 | | Minority Interest | -- | -- | -0.11 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -2.10 | 8.09 | -255.34 | | Equity Share Capital | 40.25 | 40.25 | 36.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.93 | 2.03 | -70.93 | | Diluted EPS | -0.93 | 2.03 | -70.93 | | EPS After Extra Ordinary | | Basic EPS | -0.93 | 2.03 | -70.93 | | Diluted EPS | -0.93 | 2.03 | -70.93 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
